Surveillance of Vaccine-Preventable Diseases (VPDs): Update 2017
These sessions provide updates for VPD surveillance, case investigation, and outbreak control. Both sessions feature a question and answer segment.
Goal
To enhance the surveillance of VPDs.
Objectives
- Identify 3 main levels of the national surveillance system for VPDs
- Describe the concept of surveillance indicators
- Discuss the importance of surveillance and case identification
- Describe appropriate mechanisms for surveillance
- Describe the appropriate application of case definitions, clinical descriptions, and case classifications
- List the most appropriate pathogen-specific laboratory test(s) for surveillance
- List epidemiologically important data to collect for surveillance
Target Audiences
Public health staff (including epidemiologists, program managers, etc.), health educators, laboratorians, physicians, nurses, physician assistants, and anyone else involved in surveillance and reporting of VPDs.
Recordings and Presentations
Session I: CDC subject matter experts for viral VPDs (mumps, acute flaccid myelitis/polio, varicella, measles, and rotavirus)
Download Recording
Presentation Slides
Session II: CDC subject matter experts for bacterial VPDs (meningococcal disease, pertussis, invasive pneumococcal disease, Haemophilus influenzae, and diphtheria)
Download Recording
Presentation Slides